Stock Earnings

Question 1

Silence Therapeutics PLC'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Silence Therapeutics PLC'in toplam varlıkları $0 olup, net loss $0'dir.

Question 2

SLN'ün temel finansal oranları nelerdir?

Accepted Answer

Silence Therapeutics PLC'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Silence Therapeutics PLC'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Silence Therapeutics PLC largest revenue segment is Ribonucleic Acid Therapeutics, at a revenue of 42,353,702 in the most earnings release.For geography, United Kingdom is the primary market for Silence Therapeutics PLC, at a revenue of 42,212,712.

Question 4

Silence Therapeutics PLC kârlı mı?

Accepted Answer

no, son mali tablolara göre Silence Therapeutics PLC'in net loss $0'dir.

Question 5

Silence Therapeutics PLC'in herhangi bir yükümlülüğü var mı?

Accepted Answer

no, Silence Therapeutics PLC'in yükümlülüğü 0'dir.

Question 6

Silence Therapeutics PLC'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Silence Therapeutics PLC'in toplam tedavüldeki hisse sayısı 0'dir.

Breakdown	TTM
Revenue	45
Revenue Growth (YoY)	150%
Cost of Revenue	15
Gross Profit	29
Selling, General & Admin	46
Research & Development	126
Operating Expenses	173
Other Non Operating Income (Expenses)	24
Pretax Income	-139
Income Tax Expense	-3
Net Income	-136
Net Income Growth	202%
Shares Outstanding (Diluted)	141.69
Shares Change (YoY)	1%
EPS (Diluted)	-0.97
EPS Growth	202.99%
Free Cash Flow	--
Free Cash Flow Per Share	--
Gross Margin	64.44%
Operating Margin	-317.77%
Profit Margin	-302.22%
Free Cash Flow Margin	--
EBITDA	--
EBITDA Margin	--
D&A For EBITDA	--
EBIT	-143
EBIT Margin	-317.77%
Effective Tax Rate	2.15%

Silence Therapeutics PLC (SLN) Price

SLN Stock Price Chart

SLN Income

Follow-Up Questions